We are pleased to announce that together with our partners, we have taken the necessary steps to conclude a contract with the authorized body, which will provide us with the opportunity to produce medical devices under the client's own trademark. This is another step towards full implementation of the requirements of the MDR 2017/745 Regulation, while maintaining transition periods.
This is a very important stage for us, which confirms our attention to the quality and safety of medical products that fall into the hands of our customers. Cooperation with the authorized body also confirms that we are a reliable partner in implementing ambitious plans. Now, in cooperation with the authorized body, we will continue our activities, adapting our products to the requirements of new regulations, as well as providing our partners and users with full support in the field of regulatory compliance and safety.